
浏览全部资源
扫码关注微信
纸质出版:2011
移动端阅览
周璇,孙竞,李敏,李文卿,宋晓玲,刘阳.215例血友病A患者因子Ⅷ抑制物形成的环境因素研究[J].陆军军医大学学报(原第三军医大学学报),2011,33(12):1273-1276.
Zhou Xuan,Sun Jing,Li Min,Li Wenqing,Song Xiaoling,Liu Yang.Environmental factors for inhibitor formation of factor Ⅷ in 215 patients with hemophilia A[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(12):1273-1276.
周璇,孙竞,李敏,李文卿,宋晓玲,刘阳.215例血友病A患者因子Ⅷ抑制物形成的环境因素研究[J].陆军军医大学学报(原第三军医大学学报),2011,33(12):1273-1276. DOI:
Zhou Xuan,Sun Jing,Li Min,Li Wenqing,Song Xiaoling,Liu Yang.Environmental factors for inhibitor formation of factor Ⅷ in 215 patients with hemophilia A[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(12):1273-1276. DOI:
目的 研究中国血友病A患者因子Ⅷ(FⅧ)抑制物形成的环境因素。 方法 监测215例血友病A患者在2年(2007年6月至2009年6月)的连续随访中,FⅧ抑制物发生、变化及转归,并对FⅧ抑制物形成的环境因素进行回顾性分析。 结果 215例血友病A患者随访2年FⅧ抑制物累积发生率为11.6%(25/215)。FⅧ抑制物形成的环境因素的多变量分析结果示:①输注原因中短期低剂量预防治疗比按需治疗形成FⅧ抑制物的风险低(OR=0.037,95%CI为0.002~0.616);②血友病越严重,累积暴露日越少,FⅧ抑制物形成风险越高;③发生严重出血事件是FⅧ抑制物形成的高危因素(OR=117.045,95%CI为19.333~708.617); ④输注形式和发生重大感染事件与FⅧ抑制物形成无关。 结论 在中国目前治疗情况下,血友病患者 FⅧ抑制物的形成可能与血友病严重程度、输注原因(预防治疗或按需治疗)、累积暴露日和是否发生严重出血事件有关。
Objective To study the environmental factors for inhibitor formation of factor Ⅷ in 215 Chinese patients with hemophilia A. Methods Formation
change and transformation of factor Ⅷ were observed in 215 Chinese patients with hemophilia A during the 2-year follow-up period from June 2007 to June 2009. The environmental factors for inhibitor formation of factor Ⅷ were retrospectively analyzed. Results The cumulative incidence of hemophilia A in the 215 Chinese patients during the 2-year follow-up period was 11.6% (25/215). Multivariate analysis showed that the risk for inhibitor formation of factor Ⅷ was lower in short-term low-dose preventive treatment than in on-demand treatment (OR=0.037
95%CI=0.002-0.616). The higher the severity of hemophilia was
the less the cumulative exposure day was
and the greater the risk for the inhibitor formation of factor Ⅷ was. Severe bleeding episodes was a high risk factor for the inhibitor formation of factor Ⅷ (OR=117.045
95%CI=19.333-708.617). Infusion forms and major infection events were not related with the inhibitor formation of factor Ⅷ. Conclusion Inhibitor formation of factor Ⅷ in Chinese patients with hemophilia A may be related to the severity of hemophilia
infusion treatment (preventive treatment or on-demand treatment)
cumulative exposure day and severe bleeding episodes in China at present.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621